Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • Page (2)

Publication date

Selecting an option will change the focus to the start of the list.
  • (-) April 2026 (2)
  • November 2020 (1)
  • May 2019 (1)
  • July 2013 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • (-) Measles (2)
  • Endocrine disrupting chemicals (4)

2 search results

You searched for these word(s): risk assessment
  • Measles and pregnancy

    https://www.rivm.nl/en/measles/pregnancy

    … measles and have never had measles themselves have a higher risk of severe illness due to measles. Read more about it … or they have ever been vaccinated against measles. Higher risk of severe disease Pregnant people who are not … measles and have never had measles themselves have a higher risk of severe illness due to measles, compared to people …

    Publication date: 04-13-2026
  • Measles at school or childcare

    https://www.rivm.nl/en/measles/at-school-or-childcare

    … how likely it is that others are infected. If there is a risk that your child may have contracted measles, the GGD …

    Publication date: 04-13-2026

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon